Intellia Therapeutics, Inc.NTLA stock score: 33/100

$9.52 · -2.56% · Scored Nov 19, 2026

Technical
26
Fundamental
35
News
54

The reading

Intellia Therapeutics (NTLA) scores 33 out of 100, which reads bearish, higher than 8% of Healthcare stocks and 9% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 35, technicals 26.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 15 and contrarian oscillators 70 — a split worth reading before trusting the technical total.

News sentiment is neutral at 54; it is shown, not counted in the composite.

Since Aug 22, 2026 the composite has ranged from 31 to 43, and it is down 7 points over the period.

About Intellia Therapeutics

Intellia Therapeutics (NTLA) is a genome editing company that develops medicines using CRISPR technology delivered directly into the body. Its approach packages CRISPR components in lipid nanoparticles that travel mainly to the liver, where they permanently switch off a disease-causing gene with a single treatment. Its most advanced candidate, lonvoguran ziclumeran, known as lonvo-z, is designed to prevent swelling attacks in hereditary angioedema by inactivating the KLKB1 gene, and it has produced positive late-stage trial results, which Intellia is using to seek U.S. approval. Its second major program, nexiguran ziclumeran, or nex-z, targets transthyretin amyloidosis with cardiomyopathy or polyneuropathy and is in late-stage trials in collaboration with Regeneron. Intellia has little revenue today, mainly from collaborations, and funds development with cash raised from investors.

In hereditary angioedema, Intellia would compete with Takeda, CSL Behring, BioCryst, Ionis and KalVista, while in transthyretin amyloidosis it faces Alnylam, Pfizer, BridgeBio and AstraZeneca. Among gene editing companies, it competes with CRISPR Therapeutics and Beam Therapeutics. Its edge rests on clinical data supporting one-time treatment, its delivery technology and patents. Investors who follow NTLA stock tend to watch the approval process and launch preparations for lonvo-z. Safety findings and enrollment in the nex-z trials are closely followed. Pricing, reimbursement, manufacturing and cash runway are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward NTLA’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

35

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.

  • Price-to-Sales ratio compares market capitalization to annual revenue.

36 weighted scorers; 3 had no data today and are left out rather than counted as zero.

Technical · daily

22

Pulling it up

  • Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

  • Bollinger Bands (20-period) plot standard deviations above and below a moving average.

  • Williams %R (28-period) places the close within the last 28 periods' high-low range.

Holding it back

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Simple Moving Average (20-period) represents a key short to intermediate-term trend indicator.

  • Volume Weighted Average Price (VWAP) shows the average price weighted by volume.

61 weighted scorers; 4 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
54

Technical score by timeframe

ChartScoreWeight
Hourly331
Daily223
Weekly222
Monthly332

Composite score, last 90 days

05010033Aug 22, 2026Nov 19, 2026Aug 22, 2026: 40Aug 23, 2026: 40Aug 24, 2026: 37Aug 25, 2026: 42Aug 26, 2026: 41Aug 27, 2026: 41Aug 28, 2026: 39Aug 29, 2026: 40Aug 30, 2026: 39Aug 31, 2026: 38Sep 1, 2026: 38Sep 2, 2026: 39Sep 3, 2026: 38Sep 4, 2026: 38Sep 5, 2026: 39Sep 6, 2026: 39Sep 7, 2026: 39Sep 8, 2026: 39Sep 9, 2026: 35Sep 10, 2026: 33Sep 11, 2026: 34Sep 12, 2026: 34Sep 13, 2026: 34Sep 14, 2026: 33Sep 15, 2026: 32Sep 16, 2026: 33Sep 17, 2026: 37Sep 18, 2026: 35Sep 19, 2026: 35Sep 20, 2026: 35Sep 21, 2026: 37Sep 22, 2026: 39Sep 23, 2026: 37Sep 24, 2026: 36Sep 25, 2026: 34Sep 26, 2026: 34Sep 27, 2026: 34Sep 28, 2026: 33Sep 29, 2026: 34Sep 30, 2026: 36Oct 1, 2026: 36Oct 2, 2026: 38Oct 3, 2026: 37Oct 4, 2026: 37Oct 5, 2026: 39Oct 6, 2026: 38Oct 7, 2026: 33Oct 8, 2026: 38Oct 9, 2026: 40Oct 10, 2026: 40Oct 11, 2026: 40Oct 12, 2026: 39Oct 13, 2026: 34Oct 14, 2026: 32Oct 15, 2026: 32Oct 16, 2026: 32Oct 17, 2026: 32Oct 18, 2026: 32Oct 19, 2026: 32Oct 20, 2026: 34Oct 21, 2026: 33Oct 22, 2026: 31Oct 23, 2026: 31Oct 24, 2026: 32Oct 25, 2026: 32Oct 26, 2026: 33Oct 27, 2026: 37Oct 28, 2026: 41Oct 29, 2026: 43Oct 30, 2026: 39Oct 31, 2026: 39Nov 1, 2026: 39Nov 2, 2026: 36Nov 3, 2026: 37Nov 4, 2026: 39Nov 5, 2026: 32Nov 6, 2026: 33Nov 7, 2026: 33Nov 8, 2026: 33Nov 9, 2026: 36Nov 10, 2026: 33Nov 11, 2026: 34Nov 12, 2026: 32Nov 13, 2026: 34Nov 14, 2026: 34Nov 15, 2026: 34Nov 16, 2026: 34Nov 17, 2026: 34Nov 18, 2026: 34Nov 19, 2026: 33
Show the daily numbers
DateComposite
Nov 19, 202633
Nov 18, 202634
Nov 17, 202634
Nov 16, 202634
Nov 15, 202634
Nov 14, 202634
Nov 13, 202634
Nov 12, 202632
Nov 11, 202634
Nov 10, 202633
Nov 9, 202636
Nov 8, 202633
Nov 7, 202633
Nov 6, 202633
Nov 5, 202632
Nov 4, 202639
Nov 3, 202637
Nov 2, 202636
Nov 1, 202639
Oct 31, 202639
Oct 30, 202639
Oct 29, 202643
Oct 28, 202641
Oct 27, 202637
Oct 26, 202633
Oct 25, 202632
Oct 24, 202632
Oct 23, 202631
Oct 22, 202631
Oct 21, 202633
Oct 20, 202634
Oct 19, 202632
Oct 18, 202632
Oct 17, 202632
Oct 16, 202632
Oct 15, 202632
Oct 14, 202632
Oct 13, 202634
Oct 12, 202639
Oct 11, 202640
Oct 10, 202640
Oct 9, 202640
Oct 8, 202638
Oct 7, 202633
Oct 6, 202638
Oct 5, 202639
Oct 4, 202637
Oct 3, 202637
Oct 2, 202638
Oct 1, 202636
Sep 30, 202636
Sep 29, 202634
Sep 28, 202633
Sep 27, 202634
Sep 26, 202634
Sep 25, 202634
Sep 24, 202636
Sep 23, 202637
Sep 22, 202639
Sep 21, 202637
Sep 20, 202635
Sep 19, 202635
Sep 18, 202635
Sep 17, 202637
Sep 16, 202633
Sep 15, 202632
Sep 14, 202633
Sep 13, 202634
Sep 12, 202634
Sep 11, 202634
Sep 10, 202633
Sep 9, 202635
Sep 8, 202639
Sep 7, 202639
Sep 6, 202639
Sep 5, 202639
Sep 4, 202638
Sep 3, 202638
Sep 2, 202639
Sep 1, 202638
Aug 31, 202638
Aug 30, 202639
Aug 29, 202640
Aug 28, 202639
Aug 27, 202641
Aug 26, 202641
Aug 25, 202642
Aug 24, 202637
Aug 23, 202640
Aug 22, 202640

Key facts

Market cap
$1.3B
Sector
Healthcare
Industry
Biotechnology
Beta
1.82
Risk grade (1–10)
8
Next earnings
Nov 5, 2026

Questions

What is NTLA's stock rating today?

NTLA scores 33/100 (Bearish) as of Nov 19, 2026: technical 26, fundamental 35, and news sentiment 54, which is shown but not counted. Scores are recomputed every night.

What does Intellia Therapeutics do?

Intellia Therapeutics (NTLA) is a genome editing company that develops medicines using CRISPR technology delivered directly into the body. Its approach packages CRISPR components in lipid nanoparticles that travel mainly to the liver, where they permanently switch off a disease-causing gene with a single treatment.

Is NTLA stock a buy?

The score is not a buy or sell recommendation. A 33 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the NTLA score calculated?

97 weighted scorers feed it today: 36 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

NTLA stock score

HTML

<a href="https://stocksscores.com/stocks/ntla/"><img src="https://stocksscores.com/stocks/ntla/badge.svg" alt="NTLA stock score" height="20"></a>

Markdown

[![NTLA stock score](https://stocksscores.com/stocks/ntla/badge.svg)](https://stocksscores.com/stocks/ntla/)